NM_000163.5:c.785-9G>A

Variant names:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000163.5(GHR):c.785-9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00244 in 1,178,276 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 41 hom., cov: 32)

Exomes 𝑓: 0.0011 ( 17 hom. )

Consequence

GHR
NM_000163.5 intron

Scores

Splicing: ADA: 0.0001877

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0490

Publications

0 publications found

Variant links:

Genes affected

GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]

GHR Gene-Disease associations (from GenCC):

Laron syndrome
Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
short stature due to partial GHR deficiency
Inheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

GHR links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.65).

BP6

Variant 5-42713420-G-A is Benign according to our data. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-42713420-G-A is described in CliVar as Benign. Clinvar id is 255408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BS1

Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0117 (1777/152246) while in subpopulation AFR AF = 0.0408 (1697/41550). AF 95% confidence interval is 0.0392. There are 41 homozygotes in GnomAd4. There are 842 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

BS2

High Homozygotes in GnomAd4 at 41 AR,Unknown,AD gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
GHR	NM_000163.5 link	c.785-9G>A		intron_variant	Intron 7 of 9	ENST00000230882.9	NP_000154.1	P10912-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
GHR	ENST00000230882.9 link	c.785-9G>A		intron_variant	Intron 7 of 9	1	NM_000163.5	ENSP00000230882.4		P10912-1

Frequencies

GnomAD3 genomes

AF:

0.0116

AC:

1762

AN:

152128

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0406

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00380

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000882

Gnomad OTH

AF:

0.00765

GnomAD2 exomes

AF:

0.00300

AC:

748

AN:

249370

AF XY:

0.00216

show subpopulations

Gnomad AFR exome

AF:

0.0428

Gnomad AMR exome

AF:

0.00113

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000264

Gnomad OTH exome

AF:

0.00147

GnomAD4 exome

AF:

0.00107

AC:

1100

AN:

1026030

Hom.:

Cov.:

AF XY:

0.000890

AC XY:

472

AN XY:

530252

show subpopulations

African (AFR)

AF:

0.0363

AC:

916

AN:

25244

American (AMR)

AF:

0.00152

AC:

AN:

44166

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

23422

East Asian (EAS)

AF:

0.00

AC:

AN:

37530

South Asian (SAS)

AF:

0.0000387

AC:

AN:

77560

European-Finnish (FIN)

AF:

0.00

AC:

AN:

49900

Middle Eastern (MID)

AF:

0.000608

AC:

AN:

4936

European-Non Finnish (NFE)

AF:

0.0000181

AC:

AN:

717502

Other (OTH)

AF:

0.00214

AC:

AN:

45770

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.472

Heterozygous variant carriers

107

161

214

268

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

110

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0117

AC:

1777

AN:

152246

Hom.:

Cov.:

AF XY:

0.0113

AC XY:

842

AN XY:

74436

show subpopulations

African (AFR)

AF:

0.0408

AC:

1697

AN:

41550

American (AMR)

AF:

0.00379

AC:

AN:

15292

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5186

South Asian (SAS)

AF:

0.00

AC:

AN:

4828

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10604

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0000882

AC:

AN:

67996

Other (OTH)

AF:

0.00757

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.503

Heterozygous variant carriers

181

271

362

452

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

100

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00424

Hom.:

Bravo

AF:

0.0131

Asia WGS

AF:

0.00375

AC:

AN:

3478

EpiCase

AF:

0.0000545

EpiControl

AF:

0.00

ClinVar

Significance: Benign

Submissions summary: Benign:3

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:1

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Laron-type isolated somatotropin defect

Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided

Benign:1

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.65

CADD

Benign

2.1

(source)

DANN

Benign

0.80

PhyloP100

-0.049

Mutation Taster

=100/0

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Benign

0.00019

dbscSNV1_RF

Benign

0.010

SpliceAI score (max)

0.23

Details are displayed if max score is > 0.2

DS_AL_spliceai

0.23

Position offset: 9

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over